- Home
- Services
- north america
- cell genomics
Show results for
Refine by
Cell Genomics Services In North America
7 services found
Manufactured by:Creative Biogene based inShirley, NEW YORK (USA)
Lentiviruses are powerful tools that have been widely used to efficiently transduce both replicating and quiescent cells. The regular lentiviruses are well-known for possessing the ability to stably integrate into their target cell genomes as proviruses. Integrase-deficient lentivirus (IDLV), also known as non-integrating lentivirus (NILV), is a ...
by:Ginkgo Bioworks Inc. based inBoston, MASSACHUSETTS (USA)
We’re building a high-throughput process for the engineering of mammalian cell genomes, enabling a wide range of industrial and pharmaceutical ...
Manufactured by:MedGenome Inc. based inCounty of New Castle, DELAWARE (USA)
A comprehensive suite of bioinformatics services for NGS data analysis encompassing a wide range of applications including genomics, transcriptomics, single cell genomics, immune profiling, genome assembly and annotation and more. Our team of experts combined with our advanced reporting have resulted in over 200 scientific ...
Manufactured by:Creative Biogene based inShirley, NEW YORK (USA)
CRISPR/Cas9 technology has been used as a genome-editing tool for multiple cell lines, such as tumor cell line and embryonic stem cell lines. Primary T cell, as an important class of immune cells system, play an extremely important role in immunity system. It holds great potential for therapeutic ...
Manufactured by:Creative Biogene based inShirley, NEW YORK (USA)
Genomic engineering in cell lines is a versatile tool for studying gene function, designing diseases models, biopharmaceutical research, drug discovery and many other applications. CRISPR (Clustered Regulatory Interspaced Short Palindromic Repeats)/Cas9 systems is a newly developed yet the most popular method for genome editing. It has been ...
Manufactured by:Grail, Inc. based inMenlo Park, CALIFORNIA (USA)
Mapping the Landscape of Genomic Cancer Signals in the Blood. The Circulating Cell-free Genome Atlas (CCGA) Study is a prospective, observational, longitudinal, study designed to characterize the landscape of genomic cancer signals in the blood of people with and without cancer. ...
by:Vor Biopharma based inCambridge, MASSACHUSETTS (USA)
The traditional tumor target paradigm aims to treat hematological malignancies such as acute myeloid leukemia (AML) by focusing on the specificity and potency of therapies that kill cancer cells expressing a target. However, this paradigm is limited by the expression of tumor targets on healthy cells, resulting in on-target toxicity. On-target toxicity has led to the development failure of many ...